Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Banco de datos
País como asunto
Tipo del documento
Publication year range
1.
Prev Med ; 183: 107977, 2024 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-38692309

RESUMEN

OBJECTIVE: To leverage qualitative data to explore gay and bisexual men's (GBM) perceptions about doxycycline post-exposure prophylaxis (Doxy-PEP). Doxy-PEP is a novel biomedical STI-prevention strategy that helps reduce the risk of acquiring bacterial STIs. Little is known about Doxy-PEP's acceptability in the U.S., nor how best to engage those most vulnerable to STIs in taking up this nascent prevention strategy. METHOD: Between July and September of 2023, 24 GBM from across the U.S. completed qualitative interviews about their perceptions regarding Doxy-PEP. Interviews were analyzed using a codebook approach to thematic analysis. RESULTS: Participants were generally interested in using Doxy-PEP, but were concerned about the potential for antibiotic resistance, side-effects, medication interactions to occur, along with stigmatizing discourse around its use. Meanwhile, participants were motivated by the simplicity of Doxy-PEP and the protection it could confer on both an individual and community-level- as well as its potential to reduce STI-related anxiety. Finally, participants desired additional information on Doxy-PEP to address their concerns. CONCLUSIONS: There is a need for clear guidelines and expanded public health messaging on Doxy-PEP in the U.S.


Asunto(s)
Doxiciclina , Homosexualidad Masculina , Profilaxis Posexposición , Investigación Cualitativa , Minorías Sexuales y de Género , Humanos , Masculino , Estados Unidos , Adulto , Homosexualidad Masculina/psicología , Minorías Sexuales y de Género/psicología , Enfermedades de Transmisión Sexual/prevención & control , Persona de Mediana Edad , Antibacterianos/uso terapéutico , Percepción , Entrevistas como Asunto
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda